相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Seroprevalence of Hepatitis B Virus among Adults at High Risk for HIV Transmission Two Decades after Implementation of Nationwide Hepatitis B Virus Vaccination Program in Taiwan
Hsin-Yun Sun et al.
PLOS ONE (2014)
Prophylactic Effect of Antiretroviral Therapy on Hepatitis B Virus Infection
Hiroyuki Gatanaga et al.
CLINICAL INFECTIOUS DISEASES (2013)
Prophylactic Effect of Lamivudine-Based Antiretroviral Therapy on Incident Hepatitis B Virus Infection Among HIV-Infected Patients
Wang-Huei Sheng et al.
CLINICAL INFECTIOUS DISEASES (2013)
Patterns and Causes of Suboptimal Response to Tenofovir-Based Therapy in Individuals Coinfected With HIV and Hepatitis B Virus
Gail V. Matthews et al.
CLINICAL INFECTIOUS DISEASES (2013)
Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013
Ed Wilkins et al.
HIV MEDICINE (2013)
Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan
Chun-Ju Chiang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up
Ruxandra Calin et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Immune Response to Hepatitis B Virus Vaccination Among HIV-1 Infected And Uninfected Adults in Kenya
Elizabeth Irungu et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Hepatitis B Virus (HBV) Coinfection Accelerates Immunologic Progression in Patients With Primary HIV Infection in an Area of Hyperendemicity for HBV Infection
Mao-Song Tsai et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study
Gilles Wandeler et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis
Huw Price et al.
PLOS ONE (2013)
Long-term response rates of successful hepatitis B vaccination in HIV-infected patients
Vania Baptista Lopes et al.
VACCINE (2013)
Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study
Vincent Thibault et al.
VIROLOGY JOURNAL (2013)
Differential Clinical and Virologic Impact of Hepatitis B Virus Genotypes B and C on HIV-Coinfected Patients Receiving Lamivudine-Containing Highly Active Antiretroviral Therapy
Wang-Huei Sheng et al.
CLINICAL INFECTIOUS DISEASES (2012)
Hepatitis B Virus Coinfection Negatively Impacts HIV Outcomes in HIV Seroconverters
Helen M. Chun et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Effect of Age on the Incidence of Acute Hepatitis B After 25 Years of a Universal Newborn Hepatitis B Immunization Program in Taiwan
Wei-Ju Su et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir plus emtricitabine-based HAART in HBV-HIV-coinfected patients
L. Kosi et al.
JOURNAL OF VIRAL HEPATITIS (2012)
HIV-HBV Coinfection - A Global Challenge
Athena P. Kourtis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
IFN-λ3 Inhibits HIV Infection of Macrophages through the JAK-STAT Pathway
Man-Qing Liu et al.
PLOS ONE (2012)
Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults
D. V. Potsch et al.
VACCINE (2012)
Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
J. J. Ott et al.
VACCINE (2012)
Managing hepatitis B/HIV co-infected: adding entecavir to truvada (tenofovir disoproxil/emtricitabine) experienced patients
Libuse Ratcliffe et al.
AIDS (2011)
Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues
Luz Martin-Carbonero et al.
AIDS (2011)
Telbivudine exerts no antiviral activity against HIV-1 in vitro and in humans
Noortje M. van Maarseveen et al.
ANTIVIRAL THERAPY (2011)
Elimination of Hepatocellular Carcinoma and Acute Hepatitis B in Children 25 Years After a Hepatitis B Newborn and Catch-Up Immunization Program
Brian J. McMahon et al.
HEPATOLOGY (2011)
Safety and Immunogenicity of 4 Intramuscular Double Doses and 4 Intradermal Low Doses vs Standard Hepatitis B Vaccine Regimen in Adults With HIV-1 A Randomized Controlled Trial
Odile Launay et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Efficacy of the nationwide hepatitis B infant vaccination program in Taiwan
Chen Szu-Ming et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
A Randomized Controlled Study of Accelerated Versus Standard Hepatitis B Vaccination in HIV-Positive Patients
Theodora E. M. S. de Vries-Sluijs et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co infected patient: Possible synergy with HAART ? A case report
Leonidas Chelis et al.
MEDICAL ONCOLOGY (2011)
Virologic and Clinical Outcomes of Hepatitis B Virus Infection in HIV-HBV Coinfected Transplant Recipients
C. S. Coffin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy
Paula Tuma et al.
ANTIVIRAL THERAPY (2010)
Systematic Review and Meta-analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV-Infected Patients
Ryan D. Cooper et al.
CLINICAL INFECTIOUS DISEASES (2010)
Geographical and genetic diversity of the human hepatitis B virus
Fuat Kurbanov et al.
HEPATOLOGY RESEARCH (2010)
Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe
Vincent Soriano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2010)
Sorafenib Therapy for Hepatocellular Carcinoma in an HIV-HCV Coinfected Patient: A Case Report
Giorgio Perboni et al.
ONCOLOGIST (2010)
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220
E. T. Overton et al.
VACCINE (2010)
High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects
D. V. Potsch et al.
VACCINE (2010)
Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection
Reto Nüesch et al.
AIDS (2009)
Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity
Mariagrazia Tateo et al.
AIDS (2009)
Seroprevalence of Chronic Hepatitis B Virus Infection Among Taiwanese Human Immunodeficiency Virus Type 1-Positive Persons in the Era of Nationwide Hepatitis B Vaccination
Hsin-Yun Sun et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Targeted therapies to treat non-AIDS-defining cancers in patients with HIV on HAART therapy: treatment considerations and research outlook
John F. Deeken et al.
CURRENT OPINION IN ONCOLOGY (2009)
Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a
Patrick Marcellin et al.
GASTROENTEROLOGY (2009)
2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B
Yun-Fan Liaw et al.
GASTROENTEROLOGY (2009)
Hepatitis B and Human Immunodeficiency Virus Coinfection
Chloe L. Thio
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B
Brian J. McMahon
HEPATOLOGY INTERNATIONAL (2009)
A Genetic Variant of Hepatitis B Virus Divergent from Known Human and Ape Genotypes Isolated from a Japanese Patient and Provisionally Assigned to New Genotype J
Kanako Tatematsu et al.
JOURNAL OF VIROLOGY (2009)
Hepatitis B vaccine responses in a large US military cohort of HIV-infected individuals: Another benefit of HAART in those with preserved CD4 count
Michael L. Landrum et al.
VACCINE (2009)
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy
Mario Guimaraes Pessoa et al.
AIDS (2008)
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma
Gary M. Clifford et al.
AIDS (2008)
CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years
C. L. Cooper et al.
CLINICAL INFECTIOUS DISEASES (2008)
Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults
Christina L. Bailey et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2008)
Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons
H. Nina Kim et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2008)
Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease
Susan Moir et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up
Hiromi Yatsuji et al.
JOURNAL OF HEPATOLOGY (2008)
Use of an accelerated immunization schedule for combined hepatitis A and B protection in the corporate traveler
Bradley A. Connor et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2008)
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma
Hwai-I Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
LANCET (2008)
Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy
Leilani Paitoonpong et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2008)
Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial
Jinlin Hou et al.
HEPATOLOGY (2008)
Possible New Hepatitis B Virus Genotype, Southeast Asia
Christophe M. Olinger et al.
EMERGING INFECTIOUS DISEASES (2008)
Telbivudine versus lamivudine in patients with chronic hepatitis B
Ching-Lung Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
Wang-Huei Sheng et al.
CLINICAL INFECTIOUS DISEASES (2007)
Low resistance to adefovir combined with lamivudine: A 3-year study of 145 lamivudine-resistant hepatitis B patients
Pie-Fro Lampertico et al.
GASTROENTEROLOGY (2007)
Differential antiviral effect of PEG-interferon-α-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients
A. U. Neumann et al.
AIDS (2007)
Brief report - The HBV drug entecavir - Effects on HIV-1 replication and resistance
Moira A. McMahon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Clinical implications of HIV and hepatitis B co-infection in Asia and Africa
Christopher J. Hoffmann et al.
LANCET INFECTIOUS DISEASES (2007)
Safety and tolerability of sequential pegylated IFN-α2a and tenofovir for hepatitis B infection in HIV+ individuals
R. M. Johnson et al.
HIV CLINICAL TRIALS (2007)
Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: A matched cohort study
Wang-Huei Sheng et al.
CLINICAL INFECTIOUS DISEASES (2007)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2006)
Humoral response to hepatitis B vaccination and its relationship with T CD45RA+(naive) and CD45RO+(memory) subsets in HIV-1-infected subjects
Ana Paula Rocha Veiga et al.
VACCINE (2006)
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127
Marion G. Peters et al.
HEPATOLOGY (2006)
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection
Guenther Schmutz et al.
AIDS (2006)
Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease
F. Fabrizi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy
GV Matthews et al.
AIDS (2006)
Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV
K Lacombe et al.
AIDS (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Epidemiology of viral hepatitis and HIV co-infection
MJ Alter
JOURNAL OF HEPATOLOGY (2006)
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1
Y Benhamou et al.
JOURNAL OF HEPATOLOGY (2006)
Hepatitis B virus mutations associated with antiviral therapy
A. Bartholomeusz et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: A longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline
CM Chu et al.
JOURNAL OF HEPATOLOGY (2005)
Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: A two-year study
RG Gish et al.
JOURNAL OF HEPATOLOGY (2005)
Response to interferon alfa is hepatitis B virus genotype dependent:: genotype A is more sensitive to interferon than genotype D
A Erhardt et al.
GUT (2005)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose
MO Fonseca et al.
VACCINE (2005)
HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination
CB Wang et al.
HEPATOLOGY (2004)
Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus
GJ Dore et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma
HLY Chan et al.
GUT (2004)
Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study
MF Yuen et al.
CARCINOGENESIS (2004)
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine
DJ Tenney et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: The ANRS 1236 study
F Rouet et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
Prevention of hepatitis B with the hepatitis B vaccine
GA Poland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects
MF Yuen et al.
HEPATOLOGY (2004)
Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients
AM Taburet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Four years of lamivudine treatment in Chinese patients with chronic hepatitis B
TT Chang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic
WH Sheng et al.
CLINICAL INFECTIOUS DISEASES (2004)
Determinants for sustained HBeAg response to lamivudine therapy
RN Chien et al.
HEPATOLOGY (2003)
Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects
SE Kellerman et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers
JH Kao et al.
GASTROENTEROLOGY (2003)
HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C
CT Wai et al.
HEPATOLOGY (2002)
Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients
JM Sánchez-Tapias et al.
GASTROENTEROLOGY (2002)
The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals -: Functional roles of NF-κB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter
M Gómez-Gonzalo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Evaluation of chronic hepatitis B virus (HBV) infection in coinfected patients receiving lamivudine as a component of anti-human immunodeficiency virus regimens
J Hoff et al.
CLINICAL INFECTIOUS DISEASES (2001)
分享论文
